Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Filippi

Showing results (1081-1090 of 1,157) with videos related to

Pageof 116
Sort By:
Brain : a Journal of Neurology|March 24, 2022
Progression is independent of relapse activity in early multiple sclerosis: a real-life cohort studyEmilio Portaccio, Angelo Bellinvia, Mattia Fonderico, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 26, 2013
Brain atrophy and lesion load predict long term disability in multiple sclerosisVeronica Popescu, Federica Agosta, Hanneke E Hulst, et al.
Neurology|November 24, 2025
Disability Worsening Phenotypes in Multiple Sclerosis and Impact of Disease-Modifying TreatmentsErmelinda De Meo, Ilaria Addazio, Emilio Portaccio, et al.
Neurology|September 22, 2025
Toward a Unified Definition of Progression Independent of Relapse Activity in Multiple SclerosisEmilio Portaccio, Matteo Betti, Ermelinda De Meo, et al.
Multiple Sclerosis and Related Disorders|April 15, 2025
A cross-sectional multicentre study of multishell diffusion MRI in multiple sclerosisEinar A Høgestøl, Daniel A Rinker, Ivan Maximov, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 2, 2026
A predictive tool for early treatment escalation after initiation of moderate-efficacy therapy in pediatric-onset multiple sclerosisNail Benallegue, Fabien Rollot, Pietro Iaffaldano, et al.
Neurology and Therapy|June 9, 2026
Real-World Response and Super-Response to Eptinezumab over 48 Weeks in Migraine: The Prospective Multicenter EMBRACE III StudyPiero Barbanti, Cinzia Aurilia, Massimo Filippi, et al.
JAMA Neurology|December 11, 2023
Diagnostic Performance of Cortical Lesions and the Central Vein Sign in Multiple SclerosisAlessandro Cagol, Rosa Cortese, Muhamed Barakovic, et al.
JAMA Neurology|July 25, 2022
Disease-Modifying Treatments and Time to Loss of Ambulatory Function in Patients With Primary Progressive Multiple SclerosisEmilio Portaccio, Mattia Fonderico, Pietro Iaffaldano, et al.
Journal of Neurology|July 5, 2023
Effectiveness of teriflunomide on No Evidence of Disease Activity and cognition in relapsing remitting multiple sclerosis: results of the NEDA3PLUS studyMaria Pia Amato, Roberto Bergamaschi, Diego Centonze, et al.
Pageof 116

Showing results (1081-1090 of 1,157) with videos related to

Sort By:
Pageof 116
Brain : a Journal of Neurology|March 24, 2022
Progression is independent of relapse activity in early multiple sclerosis: a real-life cohort studyEmilio Portaccio, Angelo Bellinvia, Mattia Fonderico, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 26, 2013
Brain atrophy and lesion load predict long term disability in multiple sclerosisVeronica Popescu, Federica Agosta, Hanneke E Hulst, et al.
Neurology|November 24, 2025
Disability Worsening Phenotypes in Multiple Sclerosis and Impact of Disease-Modifying TreatmentsErmelinda De Meo, Ilaria Addazio, Emilio Portaccio, et al.
Neurology|September 22, 2025
Toward a Unified Definition of Progression Independent of Relapse Activity in Multiple SclerosisEmilio Portaccio, Matteo Betti, Ermelinda De Meo, et al.
Multiple Sclerosis and Related Disorders|April 15, 2025
A cross-sectional multicentre study of multishell diffusion MRI in multiple sclerosisEinar A Høgestøl, Daniel A Rinker, Ivan Maximov, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 2, 2026
A predictive tool for early treatment escalation after initiation of moderate-efficacy therapy in pediatric-onset multiple sclerosisNail Benallegue, Fabien Rollot, Pietro Iaffaldano, et al.
Neurology and Therapy|June 9, 2026
Real-World Response and Super-Response to Eptinezumab over 48 Weeks in Migraine: The Prospective Multicenter EMBRACE III StudyPiero Barbanti, Cinzia Aurilia, Massimo Filippi, et al.
JAMA Neurology|December 11, 2023
Diagnostic Performance of Cortical Lesions and the Central Vein Sign in Multiple SclerosisAlessandro Cagol, Rosa Cortese, Muhamed Barakovic, et al.
JAMA Neurology|July 25, 2022
Disease-Modifying Treatments and Time to Loss of Ambulatory Function in Patients With Primary Progressive Multiple SclerosisEmilio Portaccio, Mattia Fonderico, Pietro Iaffaldano, et al.
Journal of Neurology|July 5, 2023
Effectiveness of teriflunomide on No Evidence of Disease Activity and cognition in relapsing remitting multiple sclerosis: results of the NEDA3PLUS studyMaria Pia Amato, Roberto Bergamaschi, Diego Centonze, et al.
Pageof 116